Intabio® develops transformative product quality analytical solutions that provide early product quality characterization for efficiency gains across all stages of development and manufacturing of biotherapeutic drugs such as monoclonal antibodies an recombinant proteins. Intabio's Blaze™ System couples imaged cIEF separations with MS mass analysis. It monitors multiple Critical Quality Attributes (CQAs) in intact biotherapeutic proteins in one 15-minute assay. For the first time, generate high-resolution mass spectra directly from your charge variant peaks.